Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 32 of the 33 references it cites were found in a registry or an index.

Correction of Sickle Cell Disease in Transgenic Mouse Models by Gene Therapy

Abstract

Sickle cell disease (SCD) is caused by a single point mutation in the human betaA globin gene that results in the formation of an abnormal hemoglobin [HbS (alpha2betaS2)]. We designed a betaA globin gene variant that prevents HbS polymerization and introduced it into a lentiviral vector we optimized for transfer to hematopoietic stem cells and gene expression in the adult red blood cell lineage. Long-term expression (up to 10 months) was achieved, without preselection, in all transplanted mice with erythroid-specific accumulation of the antisickling protein in up to 52% of total hemoglobin and 99% of circulating red blood cells. In two mouse SCD models, Berkeley and SAD, inhibition of red blood cell dehydration and sickling was achieved with correction of hematological parameters, splenomegaly, and prevention of the characteristic urine concentration defect.

Overview

Integrity signals

Registry

Crossref · 10.1126/science.1065806

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Research works printed but not linked: 3

  1. R. L. Nagel M. H. Steinberg in Disorders of Hemoglobin: Genetics Pathophysiology and Clinical Management M. H. Steinberg B. G. Forget D. R. Higgs R. L. Nagel Eds. (Cambridge Univ. Press Cambridge 2001) pp. 711–756.
  2. Supplementary Web material is available on Science Online at www.sciencemag.org/cgi/content/full/294/5550/2368/DC1.
  3. We thank A. Bank and S. Goff for HIV components and critical review of the manuscript; R. M. Bookchin and Z. Etzion for Bayer-Technicon red cell analysis; S. Pack P. Rouyer-Fessard and S. Suzuka for expert technical assistance; R. Nancel for art work; Supported by NIH grant HL554352 (M.E.F. I.M.L. C.E. R.K.H R.L.N. P.L.) INSERM (Y.B. P.L.) and Association Française contre la Myopathie (Y.B. P.L.).

Cited by

See all 579

Metadata

Authors
Pawliuk, R., Westerman, K. A., Fabry, M. E., Payen, E., Tighe, R., Bouhassira, E. E., Acharya, S. A., Ellis, J., London, I. M., Eaves, C. J., Humphries, R. K., Beuzard, Y., Nagel, R. L., & Leboulch, P.
Affiliations
  • Harvard–MIT Division of Health Sciences and Technology (US)
  • Albert Einstein College of Medicine (US)
  • Inserm (FR)
  • Hospital for Sick Children (CA)
  • University of British Columbia (CA)
  • Brigham and Women's Hospital (US)
Corresponding author
Leboulch, Philippe
Venue
Science
Published
2001-12-14
Volume
294
Issue
5550
Pages
2368-2371
ISSN
  • 0036-8075 (ISSN-L)
  • 1095-9203
OpenAlex
W2111444354
Cited by
579
References
33
Citations by year
2026: 8 · 2025: 15 · 2024: 13 · 2023: 22 · 2022: 13 · 2021: 15 · 2020: 18 · 2019: 13 · 2018: 31 · 2017: 19 · 2016: 23 · 2015: 14 · 2014: 17 · 2013: 18 · 2012: 22
Type
journal article
Language
en
Open access
closed
Locations
  • Science (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Heart, Lung, and Blood Institute (HL554352)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
  • Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
  • Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
Keywords
sickle cell disease, beta-globin gene, lentiviral vectors, hematopoietic stem cell gene therapy, transgenic mouse model, erythroid-specific gene expression, splenomegaly, red blood cell dehydration
MeSH terms
Anemia, Sickle Cell, Animals, Disease Models, Animal, Erythrocytes, Genetic Vectors, Globins, Hematopoietic Stem Cells, Hemoglobin, Sickle, Humans, Mice, Inbred C57BL, Mice, Transgenic, Oxyhemoglobins, RNA, Messenger, Thalassemia, Transduction, Genetic, Genetic Therapy, HIV-1, Gene Expression, Lentivirus, Hematopoietic Stem Cell Transplantation, Transgenes, Locus Control Region, Mice, beta-Globins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.